AI assistant
Sending…
Inogen Inc — Director's Dealing 2016
Apr 5, 2016
33625_dirs_2016-04-04_e02576d0-bbf4-40f3-b88b-881c358342b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2016-03-31
Reporting Person: Bauerlein Alison (EVP, Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-31 | Common Stock | S | 3638 | $44.00 | Disposed | 48332 | Direct |
| 2016-03-31 | Common Stock | S | 722 | $46.0089 | Disposed | 47610 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.
F2: Represents the weighted average share price of an aggregate total of 722 shares sold in the price range of $46.00 to $46.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
More from Inogen Inc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3